Information subject to change. All workshops will take place Tuesday, April 11, 2023 from 1:00 PM – 4:00 PM. There will be a coffee break from 2:30 PM – 3:00 PM.

If you would like to add a workshop to your registration and you haven’t already, please click the link in your confirmation email or email us at

Pre-Conference Workshop 1: 3D Bioprinting of Functional Tissues

3D Bioprinting of Functional Tissues

Chairs: Golnaz Karoubi, University Health Network
Amanda Juraski, University of Sao Paolo
Ruogang Zhao, University at Buffalo

Associated TWIG: Scaffolds, Matrices, and Biomaterials

3D Bioprinting has become an invaluable tool for regenerative medicine research. Of particular interest, are recent advances in bioprinting technology which allow for generation of biomimetic and functional tissues. The proposed workshop will cover recent advances in 3D bioprinting focusing on the use of smart biomaterials.

1:00 PM – 1:10 PMIntroductions & WelcomeGolnaz Karoubi
1:10 PM – 1:40 PMKeynote SpeakerSarah Gilpin
1:40 PM – 2:10 PMAcademic SpeakerAdam Feinberg
2:10 PM – 2:40 PMAcademic SpeakerDaniel Shiwarski
2:40 PM – 2:50 PMTrainee SpeakerRuchi Sharma
2:50 PM – 3:10 PMBreak
3:10 PM – 3:50 PMPanel Discussion & Questions
3:50 PM – 4:00 PMClosing RemarksGolnaz Karoubi

Pre-Conference Workshop 2: Manufacturing Organs From Patient's Own Cells

Manufacturing Organs From Patient’s Own Cells: Where Are We And What It Will Take To Get Where We Want

Chair: Joan Schanck, Wake Forest Institute for Regenerative Medicine

Associated TWIG: Stem Cells & Cell Therapies & Developmental Biology and Cell Signaling

This session will bring together experts in the field of organ engineering and will discuss the progress achieved so far and the hurdles to overcome before regenerative medicine will be able to deliver transplantable organs produced from patients’ own cells.


  • to illustrate the state of the art of organ engineering
  • to illustrate the progress obtained so far in the field
  • to identify a roadmap that should take us to the ultimate goal, namely the development of technologies that will enable solid organ bioengineering and manufacturing